McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 45,000 full-time employees. The company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.
The most recent EPS for McKesson Corp is $11.69, beating expectations of $11.67.
How did McKesson Corp MCK's revenue perform in the last quarter?
McKesson Corp revenue for the last quarter is $11.69
What is the revenue estimate for McKesson Corp?
According to 14 of Wall street analyst, the revenue estimate of McKesson Corp range from $112.53B to $100.04B
What's the earning quality score for McKesson Corp?
McKesson Corp has a earning quality score of B+/53.00306. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does McKesson Corp report earnings?
McKesson Corp next earnings report is expected in 2026-08-05
What are McKesson Corp's expected earnings?
McKesson Corp expected earnings is $102.36B, according to wall-street analysts.
Did McKesson Corp beat earnings expectations?
McKesson Corp recent earnings of $96.29B beat expectations.